GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis Treatment
| Image |  |
|---|---|
| Description | scientific article published on 24 May 2022 |
| Author/s |
author: Eric Nuermberger David Barros |
| Publication date | May 24, 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |